Ching-Shih Chen

Ching-Shih Chen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ching-Shih Chen sits on this spectrum.

Ching-Shih Chen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ching-Shih Chen sits on this spectrum.

Research.com Recognitions

• 2014 - Fellow, National Academy of Inventors
• 2004 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Best Publications

• FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia

  Paolo Neviani;Ramasamy Santhanam;Joshua J. Oaks;Anna M. Eiring

  418
  Citations

• Suberoylanilide Hydroxamic Acid Reactivates HIV From Latently Infected Cells

  Xavier Contreras;Marc Schweneker;Ching-Shih Chen;Joseph M. McCune

  407
  Citations

• Indole-3-carbinol as a chemopreventive and anti-cancer agent.

  Jing-Ru Weng;Chen-Hsun Tsai;Samuel K. Kulp;Ching-Shih Chen

  399
  Citations

• From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors

  Jiuxiang Zhu;Jui Wen Huang;Ping Hui Tseng;Ya Ting Yang

  385
  Citations

• 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.

  Samuel K. Kulp;Ya Ting Yang;Chin Chun Hung;Kuen Feng Chen

  359
  Citations

• Cyclooxygenase-2, Player or Spectator in Cyclooxygenase-2 Inhibitor-Induced Apoptosis in Prostate Cancer Cells

  Xueqin Song;Ho Pi Lin;Amy J. Johnson;Ping Hui Tseng

  335
  Citations

• Targeting histone deacetylase in cancer therapy

  Hsiang Yu Lin;Chang Shi Chen;Shuan Pei Lin;Jing Ru Weng

  265
  Citations

• Neutrophil gelatinase-associated lipocalin as a survival factor

  Zhimin Tong;Xuli Wu;Dmitriy Ovcharenko;Jiuxiang Zhu

  263
  Citations

• PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

  Paolo Neviani;Jason G. Harb;Joshua J. Oaks;Ramasamy Santhanam

  256
  Citations

• Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARγ

  Chung Wai Shiau;Chih Cheng Yang;Samuel K. Kulp;Kuen Feng Chen

  243
  Citations

• Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.

  Chang Shi Chen;Shu Chuan Weng;Ping Hui Tseng;Ho Pi Lin

  239
  Citations

• Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation

  Chang Shi Chen;Yu Chieh Wang;Hsiao Ching Yang;Po Hsien Huang

  221
  Citations

• Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.

  Jiuxiang Zhu;Xueqin Song;Ho-Pi Lin;Donn C. Young

  210
  Citations

• Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth

  Ninib Baryawno;Baldur Sveinbjörnsson;Staffan Eksborg;Ching-Shih Chen

  198
  Citations

• OSU-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species–Related Autophagy in Hepatocellular Carcinoma

  Ming Gao;Pei Yen Yeh;Yen-Shen Lu;Chih-Hung Hsu

  195
  Citations

• Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia

  Leslie A. Andritsos;Amy J. Johnson;Gerard Lozanski;William Blum

  181
  Citations

• AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis

  Chih-Chien Chou;Kuen-Haur Lee;I-Lu Lai;Dasheng Wang

  180
  Citations

• FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

  Qing Liu;Xiaobin Zhao;Frank Frissora;Yihui Ma

  177
  Citations

• Peroxisome Proliferator-Activated Receptor γ-Independent Ablation of Cyclin D1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells

  Jui Wen Huang;Chung Wai Shiau;Ya Ting Yang;Samuel K. Kulp

  176
  Citations

• Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone

  Rosemary E. Teresi;Chung-Wai Shaiu;Ching-Shih Chen;V. Krishna Chatterjee

  168
  Citations